Status:
UNKNOWN
Association of Hb F Level With Clinical Severity of Beta Thalassemia
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Collaborating Sponsors:
ZhuHai Hospital
Shenzhen Children's Hospital
Conditions:
Beta Thalassemia
Eligibility:
All Genders
Brief Summary
The production of Hb F after birth is an important factor in modifying the clinical severity of beta thalassemia because an increased gamma-globin level will bind the additional a-globin and form Hb F...
Eligibility Criteria
Inclusion
- Diagnosed with beta-thalassemia
Exclusion
- Iron Deficiency Anemia
Key Trial Info
Start Date :
December 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT04917978
Start Date
December 1 2019
End Date
December 30 2025
Last Update
June 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southern Medical University
Guangzhou, Guangdong, China, 510515